Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tandem Diabetes Care (TNDM) Inventory Average (2016 - 2025)

Tandem Diabetes Care's Inventory Average history spans 12 years, with the latest figure at $133.0 million for Q4 2025.

  • For Q4 2025, Inventory Average fell 11.92% year-over-year to $133.0 million; the TTM value through Dec 2025 reached $133.0 million, down 11.92%, while the annual FY2025 figure was $139.2 million, 9.48% down from the prior year.
  • Inventory Average reached $133.0 million in Q4 2025 per TNDM's latest filing, down from $139.9 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $157.8 million in Q2 2024 to a low of $65.3 million in Q1 2021.
  • Average Inventory Average over 5 years is $118.4 million, with a median of $136.3 million recorded in 2023.
  • Peak YoY movement for Inventory Average: skyrocketed 66.08% in 2023, then dropped 11.92% in 2025.
  • A 5-year view of Inventory Average shows it stood at $67.1 million in 2021, then skyrocketed by 60.77% to $107.9 million in 2022, then surged by 39.62% to $150.7 million in 2023, then increased by 0.21% to $151.0 million in 2024, then dropped by 11.92% to $133.0 million in 2025.
  • Per Business Quant, the three most recent readings for TNDM's Inventory Average are $133.0 million (Q4 2025), $139.9 million (Q3 2025), and $141.9 million (Q2 2025).